SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-004888
Filing Date
2019-02-27
Accepted
2019-02-27 16:06:42
Documents
92
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dvax-10k_20181231.htm 10-K 3269287
2 EX-21.1 dvax-ex211_13.htm EX-21.1 1455
3 EX-23.1 dvax-ex231_15.htm EX-23.1 3650
4 EX-31.1 dvax-ex311_17.htm EX-31.1 18283
5 EX-31.2 dvax-ex312_14.htm EX-31.2 18203
6 EX-32.1 dvax-ex321_9.htm EX-32.1 6280
7 EX-32.2 dvax-ex322_12.htm EX-32.2 6349
  Complete submission text file 0001564590-19-004888.txt   11194101

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dvax-20181231.xml EX-101.INS 2448157
9 XBRL TAXONOMY EXTENSION SCHEMA dvax-20181231.xsd EX-101.SCH 75069
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20181231_cal.xml EX-101.CAL 72384
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20181231_def.xml EX-101.DEF 296932
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20181231_lab.xml EX-101.LAB 589136
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20181231_pre.xml EX-101.PRE 460914
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34207 | Film No.: 19637677
SIC: 2834 Pharmaceutical Preparations